DPP6 and cancer: Due to the species-specific nature of the nanobody, we performed all in vivo validation steps in humanized mouse models, i.e. mice implanted either with insulin-producing EndoC-βH1 cells in the quadriceps or femoris muscle, or xenografted in the subcutaneous tissue with the neuronal Kelly cancer line that spontaneously expresses DPP6.